Pancreatic Cancer Research

ResearcherSichuan Academy of Medical Sciences & Sichuan Provincial People's HospitalNo recent work listed

Ning An

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8018-4238; OpenAlex author ID A5101695847. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper

Papers 2

  1. The germline/somatic DNA damage repair gene mutations modulate the therapeutic response in Chinese patients with advanced pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s12967-021-02972-6↗
  2. The Long Noncoding RNA HOST2 Promotes Gemcitabine Resistance in Human Pancreatic Cancer Cells. Co-author DOI 10.1007/s12253-018-0486-5↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Donghui Cheng · 1 shared paper, 2020 · strength 0.24
  2. Shuangshuang Li · 1 shared paper, 2021 · strength 0.12
  3. Heli Gao · 1 shared paper, 2021 · strength 0.12
  4. Yi Cheng · 1 shared paper, 2021 · strength 0.12
  5. Li Mao · 1 shared paper, 2021 · strength 0.12
  6. Dan Cao · 1 shared paper, 2021 · strength 0.12
  7. Ang Li · 1 shared paper, 2021 · strength 0.12
  8. Lin Shui · 1 shared paper, 2021 · strength 0.12
  9. Bole Tian · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.